NIH Rebuffed, Rethinks New Ethics Regulations

Following a storm of criticism, HHS chief Sullivan asks for another plan to stem conflicts of interest. WASHINGTON--As soon as he read them, James Wyngaarden knew that there would be problems. The former National Institutes of Health director expected the agency to propose guidelines to eliminate potential conflicts of interest by government-funded university scientists who are carrying out clinical trials. But instead of directing a surgical strike against questionable financial relationships

Written byJeffrey Mervis
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share


Following a storm of criticism, HHS chief Sullivan asks for another plan to stem conflicts of interest.
WASHINGTON--As soon as he read them, James Wyngaarden knew that there would be problems. The former National Institutes of Health director expected the agency to propose guidelines to eliminate potential conflicts of interest by government-funded university scientists who are carrying out clinical trials. But instead of directing a surgical strike against questionable financial relationships among that group of researchers, NIH had issued a sweeping proposal that shocked and angered nearly every segment of the biomedical community (The Scientist, Oct. 16, 1989, page 1).

"I was astounded," says Wyngaarden, who left NIH six weeks before the guidelines were issued on September 15 and is now associate director for life sciences at the White House Office of Science and Technology Policy. "I called Bill Raub right away," says Wyngaarden, referring to his former deputy and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026, Issue 1

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Skip the Wait for Protein Stability Data with Aunty

Skip the Wait for Protein Stability Data with Aunty

Unchained Labs
Graphic of three DNA helices in various colors

An Automated DNA-to-Data Framework for Production-Scale Sequencing

illumina
Exploring Cellular Organization with Spatial Proteomics

Exploring Cellular Organization with Spatial Proteomics

Abstract illustration of spheres with multiple layers, representing endoderm, ectoderm, and mesoderm derived organoids

Organoid Origins and How to Grow Them

Thermo Fisher Logo

Products

Brandtech Logo

BRANDTECH Scientific Introduces the Transferpette® pro Micropipette: A New Twist on Comfort and Control

Biotium Logo

Biotium Launches GlycoLiner™ Cell Surface Glycoprotein Labeling Kits for Rapid and Selective Cell Surface Imaging

Colorful abstract spiral dot pattern on a black background

Thermo Scientific X and S Series General Purpose Centrifuges

Thermo Fisher Logo
Abstract background with red and blue laser lights

VANTAstar Flexible microplate reader with simplified workflows

BMG LABTECH